117 related articles for article (PubMed ID: 37922631)
21. Ninety-Day Mortality as a Reporting Parameter for High-Grade Serous Ovarian Cancer Cytoreduction Surgery.
Spencer RJ; Hacker KE; Griggs JJ; Rice LW; Reynolds RK; Uppal S
Obstet Gynecol; 2017 Aug; 130(2):305-314. PubMed ID: 28697111
[TBL] [Abstract][Full Text] [Related]
22. Travel distance, hospital volume and their association with ovarian cancer short- and long-term outcomes.
Knisely A; Huang Y; Melamed A; Tergas AI; St Clair CM; Hou JY; Khoury-Collado F; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2020 Aug; 158(2):415-423. PubMed ID: 32456990
[TBL] [Abstract][Full Text] [Related]
23. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
Mascarenhas C; Lambe M; Bellocco R; Bergfeldt K; Riman T; Persson I; Weiderpass E
Int J Cancer; 2006 Dec; 119(12):2907-15. PubMed ID: 16998830
[TBL] [Abstract][Full Text] [Related]
24. Recreational physical activity and survival in African-American women with ovarian cancer.
Abbott SE; Camacho F; Peres LC; Alberg AJ; Bandera EV; Bondy M; Cote ML; Funkhouser E; Moorman PG; Peters ES; Qin B; Schwartz AG; Barnholtz-Sloan J; Terry P; Schildkraut JM
Cancer Causes Control; 2018 Jan; 29(1):77-86. PubMed ID: 29188593
[TBL] [Abstract][Full Text] [Related]
25. Hormone replacement therapy after surgery for epithelial ovarian cancer.
Saeaib N; Peeyananjarassri K; Liabsuetrakul T; Buhachat R; Myriokefalitaki E
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012559. PubMed ID: 31989588
[TBL] [Abstract][Full Text] [Related]
26. Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.
Tattersall A; Ryan N; Wiggans AJ; Rogozińska E; Morrison J
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD007929. PubMed ID: 35170751
[TBL] [Abstract][Full Text] [Related]
27. Endometriosis and the subsequent risk of epithelial ovarian cancer.
Chang WH; Wang KC; Lee WL; Huang N; Chou YJ; Feng RC; Yen MS; Huang BS; Guo CY; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):530-5. PubMed ID: 25510696
[TBL] [Abstract][Full Text] [Related]
28. Functional not chronologic age: Frailty index predicts outcomes in advanced ovarian cancer.
Kumar A; Langstraat CL; DeJong SR; McGree ME; Bakkum-Gamez JN; Weaver AL; LeBrasseur NK; Cliby WA
Gynecol Oncol; 2017 Oct; 147(1):104-109. PubMed ID: 28734497
[TBL] [Abstract][Full Text] [Related]
29. Case-mix adjustment to compare hospital performances regarding complications after cytoreductive surgery for ovarian cancer: a nationwide population-based study.
Algera MD; Baldewpersad Tewarie NMS; Driel WJV; van Ham MAPC; Slangen BFM; Kruitwagen RFPM; Wouters MWJM;
Int J Gynecol Cancer; 2023 Apr; 33(4):534-542. PubMed ID: 36581486
[TBL] [Abstract][Full Text] [Related]
30. Impact of care by gynecologic oncologists on primary ovarian cancer survival: A population-based study.
Bouchard-Fortier G; Gien LT; Sutradhar R; Chan WC; Krzyzanowska MK; Liu SL; Ferguson SE
Gynecol Oncol; 2022 Mar; 164(3):522-528. PubMed ID: 35063277
[TBL] [Abstract][Full Text] [Related]
31. Non-surgical management of ovarian cancer: Prevalence and implications.
Shalowitz DI; Epstein AJ; Ko EM; Giuntoli RL
Gynecol Oncol; 2016 Jul; 142(1):30-37. PubMed ID: 27107721
[TBL] [Abstract][Full Text] [Related]
32. Incidence of and risk factors associated with lung metastases in newly diagnosed epithelial ovarian cancer with a look on prognosis after diagnosis: a population-based cohort study of the SEER database.
Xu J; Hussain I; Wang L; Deng K; Zhao L; Zhou K; Zhang L; Xu Z; Li K
Arch Gynecol Obstet; 2021 Oct; 304(4):1007-1020. PubMed ID: 33635405
[TBL] [Abstract][Full Text] [Related]
33. Incidence, Mortality and Survival Analysis of Epithelial Ovarian Cancer in Brunei Darussalam.
Leong E; Ong SK; Jali F; Naing L
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1415-1423. PubMed ID: 35485704
[TBL] [Abstract][Full Text] [Related]
34. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium.
Cannioto RA; LaMonte MJ; Kelemen LE; Risch HA; Eng KH; Minlikeeva AN; Hong CC; Szender JB; Sucheston-Campbell L; Joseph JM; Berchuck A; Chang-Claude J; Cramer DW; DeFazio A; Diergaarde B; Dörk T; Doherty JA; Edwards RP; Fridley BL; Friel G; Goode EL; Goodman MT; Hillemanns P; Hogdall E; Hosono S; Kelley JL; Kjaer SK; Klapdor R; Matsuo K; Odunsi K; Nagle CM; Olsen CM; Paddock LE; Pearce CL; Pike MC; Rossing MA; Schmalfeldt B; Segal BH; Szamreta EA; Thompson PJ; Tseng CC; Vierkant R; Schildkraut JM; Wentzensen N; Wicklund KG; Winham SJ; Wu AH; Modugno F; Ness RB; Jensen A; Webb PM; Terry K; Bandera EV; Moysich KB
Br J Cancer; 2016 Jun; 115(1):95-101. PubMed ID: 27299959
[TBL] [Abstract][Full Text] [Related]
35. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract][Full Text] [Related]
36. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
J Am Coll Surg; 2015 May; 220(5):940-50. PubMed ID: 25840536
[TBL] [Abstract][Full Text] [Related]
37. Survival outcomes for robotic-assisted laparoscopy versus traditional laparoscopy in clinical stage I epithelial ovarian cancer.
Facer B; Wang F; Grijalva CG; Alvarez RD; Shu XO
Am J Obstet Gynecol; 2020 May; 222(5):474.e1-474.e12. PubMed ID: 31715149
[TBL] [Abstract][Full Text] [Related]
38. Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.
Galvan-Turner VB; Chang J; Ziogas A; Bristow RE
Gynecol Oncol; 2015 Dec; 139(3):495-9. PubMed ID: 26387962
[TBL] [Abstract][Full Text] [Related]
39. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
40. The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study.
Lee WL; Chang WH; Wang KC; Guo CY; Chou YJ; Huang N; Huang HY; Yen MS; Wang PH
Medicine (Baltimore); 2015 Sep; 94(39):e1633. PubMed ID: 26426652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
